Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study [NA]
This clinical trial update reports the completion of the ASCENT pain management intervention study with results posted for a future pragmati…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Augmented Virtual Reality for Reducing Pain, Stress, Anxiety and Improve Self Efficacy in Adult Cancer Patients Undergoing Chemotherapy in The West Bank [NA]
This completed clinical trial evaluated augmented virtual reality as a nonpharmacologic approach to reduce pain, stress, and anxiety and to …
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: The Effects of Anthracycline-based Chemotherapy on Peripheral Vascular Function
The document reports a completed clinical trial evaluating the effects of anthracycline-based chemotherapy on peripheral vascular function.
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K) [Phase 2]
This Clinical Trial Update reports that ipatasertib is being tested as a targeted therapy for cancers with AKT genetic alterations in the NC…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma [Phase 1]
Phase 1 pharmacokinetic and pharmacodynamic study of DZ-002 in patients with advanced solid malignancies or lymphoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors [Phase 1]
Phase 1 results for a Granzyme B PET imaging agent studied as a predictor of response to checkpoint inhibitor immunotherapy in adults with s…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals [NA]
A clinical trial (ImmunoCARE) evaluated rapid, accurate COVID-19 testing to reduce hospitalizations among immunocompromised individuals. The…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide [Phase 2]
Phase 2 clinical trial evaluating HLA-mismatched unrelated donor bone marrow transplantation with post-transplant cyclophosphamide; the stud…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: PROactive Evaluation of Function to Avoid CardioToxicity [Phase 2]
The Phase 2 PROactive trial evaluating strategies to prevent cardiotoxicity in cancer patients was terminated, and results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence [Phase 1, Phase 2]
A Phase 1/2 trial of checkpoint inhibition after autologous stem cell transplantation for patients at high risk of post-transplant recurrenc…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone [EARLY_Phase 1]
An early-phase 1 trial from MD Anderson examines whether a nutrition and physical activity program can prevent excess weight gain in pediatr…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas [Phase 2]
A Phase 2 clinical trial is evaluating the combination of entinostat and pembrolizumab for relapsed and refractory lymphoma, with status lis…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas [Phase 1]
A Phase I clinical trial evaluating indenoisoquinolines LMP400 and LMP776 in adults with relapsed solid tumors and lymphomas has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: 9-ING-41 in Pediatric Patients With Refractory Malignancies. [Phase 1]
Phase 1 trial of 9-ING-41 in pediatric patients with refractory malignancies was terminated; the update does not include study results.
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Pilot Study of an NTproBNP Guided Strategy of Cardioprotection [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating an NTproBNP-guided cardioprotection strategy to reduce chemotherapy-related cardiotoxicity in cancer …
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers [Phase 1]
Phase 1 study results for TTX-030 as a single agent and in combination with immunotherapy or chemotherapy in patients with advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer
Completed clinical trial from Institut Bergonié evaluating elderly patients' expectations and priorities for a first-line cancer treatment a…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas [Phase 1]
Phase 1 trial assessing safety and pharmacokinetics of HMPL-689 in patients with lymphoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (In Vivo Phase) [NA]
Sponsored by the University of Exeter, the DOLPHIN-VIVO trial (NCT05010369) investigates in vivo diagnosis of lymphoma. The study has been t…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas [Phase 1, Phase 2]
The PROCLAIM-CX-072 Phase 1/2 trial evaluating CX-072 for solid tumors and lymphomas has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer's rituximab biosimilar intravenous infusion (100 mg and 500 mg) was investigated in a post-marketing database study for lymphoma, and…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: A Study of the Safety and Efficacy of EBV Specific T-cell Lines [Phase 1, Phase 2]
A completed Phase 1/2 study evaluated the safety and efficacy of Epstein-Barr virus–specific T-cell lines in patients with Epstein-Barr viru…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab [Phase 1]
This is a Phase 1/Ib study of NIZ985 alone and in combination with spartalizumab, sponsored by Novartis, which has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas [Phase 1]
This ClinicalTrials.gov update reports a Phase 1 dose-finding and safety study of CC-220, alone and in combination with an anti-CD20 monoclo…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Improving Patient Experience: BMBA [NA]
The BMBA clinical trial sponsored by Thomas Jefferson University has completed, but no specific results are provided in the update.